Navigating the Evolving Landscape of Glomerular Disease Clinical Trials

Protocol Deviations Can Put Primary Endpoints at Risk. Register to Prepare.

Executing clinical trials in complex glomerular diseases require moving beyond traditional functional involvement. As treatment paradigms and regulatory expectations for surrogate endpoints evolve, integrating medical oversight, Advanced Clinical Practitioners (ACPs) and Clinical Operations (ClinOps) from early startup through study closeout is critical to trial success. This webinar explores how an integrated, cross-functional approach can support glomerular disease clinical trials from protocol design through study execution.
This webinar presents a practical cross-functional blueprint that bridges early sponsor engagement and protocol design with seamless execution at the site level, while maintaining optimized trial management and regulatory compliance. The featured speakers will explore how embedding nephrology-experienced ACPs alongside therapeutically aligned Medical Monitors and CTMs can help reduce protocol deviations, safeguard primary endpoints and accelerate trial delivery for transformative renal therapies.
Additionally, the discussion will examine how sponsors can leverage transferable experience across glomerular disease indications even when disease-specific precedent is limited, applying integrated clinical expertise to evolving endpoint considerations and complex trial procedures.
Register for this webinar to learn how cross-functional clinical expertise can strengthen the design and execution of glomerular disease clinical trials.

Who Should Attend
This webinar will appeal to VPs, Directors, Managers and Department Heads working within:
Clinical Affairs
Clinical Research
Clinical Pharmacology
Clinical Outsourcing
Project Management
Regulatory Affairs
Medical Affairs

What You Will Learn
Attendees will learn how to:
Assess how evolving regulatory expectations and surrogate markers (e.g., proteinuria, eGFR slope) impact study design across glomerular indications
Structure early collaboration among Medical Monitors, ACPs and CTMs to eliminate departmental silos and align clinical strategy with operational execution
Deploy practical, ACP-enhanced strategies to dramatically reduce protocol deviations and ensure data integrity
Apply cross-functional, therapeutically aligned expertise to streamline site onboarding, resolve eligibility queries faster and enhance data quality in rare disease populations

Register free on Xtalks:
https://xtalks.com/webinars/navigating-the-evolving-landscape-of-glomerular-disease-clinical-trials/